IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 09/28/18

ImmunoPrecise Closes Oversubscribed Private Placement Raising $9.1M Canada NewsWire VICTORIA, Sept. 28, 2018 VICTORIA , Sept. 28, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) announces that it has closed its ...

The Centre for Drug Research and Development (CDRD) selected ImmunoPrecise's Chief Scientific Officer, Dr. Deanna Dryhurst as member of the CDRD Academy Executive Institute. Canada NewsWire VICTORIA, Sept. 21, 2018 VICTORIA , Sept. 21, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIE...

ImmunoPrecise and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery Canada NewsWire VICTORIA, Aug. 30, 2018 Co-offering Agreement combines ImmunoPrecise's advanced hybridoma plus B cell screening and sorting serv...

ImmunoPrecise Antibodies' Annual Revenues Increase 106% to $5.4 Million Canada NewsWire VICTORIA, BC, Aug. 29, 2018 VICTORIA, BC , Aug. 29, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise") (TSXV: IPA) (Pink Sheets: IPATF) today reports its financial results ...

ImmunoPrecise Increases Private Placement Financing to $7 Million Canada NewsWire VICTORIA, Aug. 28, 2018 VICTORIA , Aug. 28, 2018 /CNW/ -  IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has increased i...

ImmunoPrecise Announces $2 Million Financing Canada NewsWire VICTORIA, Aug. 22, 2018 VICTORIA , Aug. 22, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it proposes to complete a non-brokered priva...

ImmunoPrecise Announces the Resignation of Director Canada NewsWire VICTORIA, Aug. 20, 2018 VICTORIA , Aug. 20, 2018 /CNW/ -  IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that Mr. Guy Champagne , has resigne...

ImmunoPrecise Accelerates the Launch of its European, Full-service, B-cell Facility Canada NewsWire VICTORIA, July 18, 2018 VICTORIA , July 18, 2018 /CNW/ - To meet global demand, IMMUNOPRECISE ANTIBODIES LTD.  ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA) (OTC PINK...

ImmunoPrecise Closes Private Placement Financing Canada NewsWire VICTORIA, June 19, 2018 VICTORIA , June 19, 2018 /CNW/ -  IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has closed its previously announ...

ImmunoPrecise Increases Private Placement Financing Canada NewsWire VICTORIA, May 30, 2018 VICTORIA , May 30, 2018 /CNW/ -  IMMUNOPRECISE ANTIBODIES LTD. ("ImmunoPrecise" or "IPA") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has increased its previously an...